Singular Health Boosts Balance Sheet With Follow-On Marin and Sons Investment

Singular Health Group (ASX:SHG) strengthened its balance sheet through an investment of AU$773,000 from Marin and Sons, according to a Wednesday filing with the Australian Securities Exchange. The inv

MT NewswiresMay 14 23:35 ET

Singular Health Secures Key Certification Anew for Medical Device Development, Production; Shares Decline 12%

Singular Health Group (ASX:SHG) was reissued an ISO13485:2016 certificate, confirming its capability in designing and developing software-as-a-medical device for diagnostic review, the medical technol

MT NewswiresFeb 19 20:40 ET

Singular Health Group to Raise $4 Million From Share Placement; Shares Slide 17%

Singular Health Group (ASX:SHG) plans to raise about AU$4.1 million from investors through the issuance of 36,843,111 ordinary shares at AU$0.11 apiece, a Wednesday filing said. Proceeds from the issu

MT NewswiresFeb 13 23:03 ET

Singular Health Group Receives AU$850,000 From CG1 Ventures

Singular Health Group (ASX:SHG) received remittance confirmation for the full AU$850,000 of committed funds from CG1 Ventures. The medical technology company also entered into a funding agreement with

MT NewswiresFeb 9 02:59 ET

Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade

Australian shares ended their eight-day winning streak on Thursday, tracking the losses of their Wall Street peers after the US Federal Reserve doused market hopes of a March rate cut. The S&P/ASX 200

MT NewswiresFeb 1 00:45 ET

Singular Health Shares Jump 49% After Securing US Purchase Order

Singular Health Group (ASX:SHG) secured a two-year contract valued at about AU$152,000 with Roseman University of Health Sciences in Nevada, US. The purchase order comprises 50 3Dicom R&D licenses and

MT NewswiresJan 31 23:58 ET